APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Renal Disease

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Renal Disease Market Outlook and Growth Opportunities 2026

3 May 2026193 pages

Choose your research edition.

Industry ResearchVeterinary Renal Disease Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Renal Disease Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Veterinary Renal Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Renal Disease Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Renal Disease Market Analysis and Forecast 2026-2032182 pages · $4,950 USD

Market perspective

The global Veterinary Renal Disease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Renal Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Renal Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Renal Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Renal Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Renal Disease market include Zoetis, Nestle Purina PetCare, Mars, Hill's Pet Nutrition, The J.M. Smucker Company, General Mills, Merck, Elanco Animal Health and Phibro Animal Health Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Renal Disease market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Renal Disease and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Renal Disease revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Renal Disease market.

Veterinary Renal Disease Segment by Company

Zoetis

Nestle Purina PetCare

Mars

Hill's Pet Nutrition

The J.M. Smucker Company

General Mills

Merck

Elanco Animal Health

Phibro Animal Health Corporation

Ceva Sante Animale

Veterinary Renal Disease Segment by Type

Diagnosis

Treatment

Others

Veterinary Renal Disease Segment by Application

Veterinary Hospitals & Clinics

Pet Speciality Stores

Others

Veterinary Renal Disease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Renal Disease status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Renal Disease key companies, revenue, market share, and recent developments.

3. To split the Veterinary Renal Disease breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Renal Disease market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Renal Disease significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Renal Disease competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Renal Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Renal Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Renal Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Renal Disease industry.

Chapter 3: Detailed analysis of Veterinary Renal Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Renal Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Renal Disease in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Renal Disease Industry Trends Table 2. Veterinary Renal Disease Industry Drivers Table 3. Veterinary Renal Disease Industry Opportunities and Challenges Table 4. Veterinary Renal Disease Industry Restraints Table 5. Global Veterinary Renal Disease Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Renal Disease Revenue Share by Company (2021-2026) Table 7. Global Veterinary Renal Disease Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Renal Disease Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Renal Disease Company, Product Type & Application Table 10. Global Veterinary Renal Disease Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Renal Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Diagnosis Table 15. Significant Companies of Treatment Table 16. Significant Companies of Others Table 17. Global Veterinary Renal Disease Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Veterinary Renal Disease Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Veterinary Renal Disease Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Veterinary Renal Disease Sales Value Share by Type (2021-2026) Table 21. Global Veterinary Renal Disease Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Veterinary Hospitals & Clinics Table 23. Significant Companies of Pet Speciality Stores Table 24. Significant Companies of Others Table 25. Global Veterinary Renal Disease Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Veterinary Renal Disease Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Veterinary Renal Disease Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Veterinary Renal Disease Sales Value Share by Application (2021-2026) Table 29. Global Veterinary Renal Disease Sales Value Share by Application (2027-2032) Table 30. Global Veterinary Renal Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Veterinary Renal Disease Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Veterinary Renal Disease Sales Value Share by Region (2021-2026) Table 33. Global Veterinary Renal Disease Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Veterinary Renal Disease Sales Value Share by Region (2027-2032) Table 35. Global Veterinary Renal Disease Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Veterinary Renal Disease Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Veterinary Renal Disease Sales Value Market Share by Country (2021-2026) Table 38. Global Veterinary Renal Disease Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Veterinary Renal Disease Sales Value Market Share by Country (2027-2032) Table 40. Zoetis Company Information Table 41. Zoetis Business Overview Table 42. Zoetis Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Zoetis Veterinary Renal Disease Product Portfolio Table 44. Zoetis Recent Development Table 45. Nestle Purina PetCare Company Information Table 46. Nestle Purina PetCare Business Overview Table 47. Nestle Purina PetCare Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Nestle Purina PetCare Veterinary Renal Disease Product Portfolio Table 49. Nestle Purina PetCare Recent Development Table 50. Mars Company Information Table 51. Mars Business Overview Table 52. Mars Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Mars Veterinary Renal Disease Product Portfolio Table 54. Mars Recent Development Table 55. Hill's Pet Nutrition Company Information Table 56. Hill's Pet Nutrition Business Overview Table 57. Hill's Pet Nutrition Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Hill's Pet Nutrition Veterinary Renal Disease Product Portfolio Table 59. Hill's Pet Nutrition Recent Development Table 60. The J.M. Smucker Company Company Information Table 61. The J.M. Smucker Company Business Overview Table 62. The J.M. Smucker Company Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. The J.M. Smucker Company Veterinary Renal Disease Product Portfolio Table 64. The J.M. Smucker Company Recent Development Table 65. General Mills Company Information Table 66. General Mills Business Overview Table 67. General Mills Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. General Mills Veterinary Renal Disease Product Portfolio Table 69. General Mills Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck Veterinary Renal Disease Product Portfolio Table 74. Merck Recent Development Table 75. Elanco Animal Health Company Information Table 76. Elanco Animal Health Business Overview Table 77. Elanco Animal Health Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Elanco Animal Health Veterinary Renal Disease Product Portfolio Table 79. Elanco Animal Health Recent Development Table 80. Phibro Animal Health Corporation Company Information Table 81. Phibro Animal Health Corporation Business Overview Table 82. Phibro Animal Health Corporation Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Phibro Animal Health Corporation Veterinary Renal Disease Product Portfolio Table 84. Phibro Animal Health Corporation Recent Development Table 85. Ceva Sante Animale Company Information Table 86. Ceva Sante Animale Business Overview Table 87. Ceva Sante Animale Veterinary Renal Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Ceva Sante Animale Veterinary Renal Disease Product Portfolio Table 89. Ceva Sante Animale Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Veterinary Renal Disease Product Image Figure 2. Global Veterinary Renal Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Renal Disease Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Renal Disease Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Diagnosis Image Figure 8. Treatment Image Figure 9. Others Image Figure 10. Global Veterinary Renal Disease Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Veterinary Renal Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Renal Disease Sales Value Share by Type (2021-2032) Figure 13. Veterinary Hospitals & Clinics Image Figure 14. Pet Speciality Stores Image Figure 15. Others Image Figure 16. Global Veterinary Renal Disease Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Veterinary Renal Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Renal Disease Sales Value Share by Application (2021-2032) Figure 19. Global Veterinary Renal Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Veterinary Renal Disease Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Veterinary Renal Disease Sales Value (2021-2032) & (US$ Million) Figure 22. North America Veterinary Renal Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Veterinary Renal Disease Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Veterinary Renal Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Veterinary Renal Disease Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Veterinary Renal Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Veterinary Renal Disease Sales Value (2021-2032) & (US$ Million) Figure 28. South America Veterinary Renal Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Veterinary Renal Disease Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Veterinary Renal Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Veterinary Renal Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnosis
  • Treatment
  • Others
Applications
  • Veterinary Hospitals & Clinics
  • Pet Speciality Stores
  • Others
Companies covered
  • Zoetis
  • Nestle Purina PetCare
  • Mars
  • Hill's Pet Nutrition
  • The J.M. Smucker Company
  • General Mills
  • Merck
  • Elanco Animal Health
  • Phibro Animal Health Corporation
  • Ceva Sante Animale

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Renal Disease Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Renal Disease Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Renal Disease Market Dynamics
  1. 2.1 Veterinary Renal Disease Industry Trends
  2. 2.2 Veterinary Renal Disease Industry Drivers
  3. 2.3 Veterinary Renal Disease Industry Opportunities and Challenges
  4. 2.4 Veterinary Renal Disease Industry Restraints
3 Veterinary Renal Disease Market by Company
  1. 3.1 Global Veterinary Renal Disease Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Renal Disease Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Renal Disease Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Renal Disease Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Renal Disease Company Product Type and Application
  6. 3.6 Global Veterinary Renal Disease Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Renal Disease Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Renal Disease Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Renal Disease Market by Type
  1. 4.1 Veterinary Renal Disease Type Introduction
  2. 4.1.1 Diagnosis
  3. 4.1.2 Treatment
  4. 4.1.3 Others
  5. 4.2 Global Veterinary Renal Disease Sales Value by Type
  6. 4.2.1 Global Veterinary Renal Disease Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Renal Disease Sales Value by Type (2021-2032)
  8. 4.2.3 Global Veterinary Renal Disease Sales Value Share by Type (2021-2032)
5 Veterinary Renal Disease Market by Application
  1. 5.1 Veterinary Renal Disease Application Introduction
  2. 5.1.1 Veterinary Hospitals & Clinics
  3. 5.1.2 Pet Speciality Stores
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Renal Disease Sales Value by Application
  6. 5.2.1 Global Veterinary Renal Disease Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Renal Disease Sales Value by Application (2021-2032)
  8. 5.2.3 Global Veterinary Renal Disease Sales Value Share by Application (2021-2032)
6 Veterinary Renal Disease Regional Value Analysis
  1. 6.1 Global Veterinary Renal Disease Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Renal Disease Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Renal Disease Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Renal Disease Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Renal Disease Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Renal Disease Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Renal Disease Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Renal Disease Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Renal Disease Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Renal Disease Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Renal Disease Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Renal Disease Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Renal Disease Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Renal Disease Sales Value Share by Country, 2025 VS 2032
7 Veterinary Renal Disease Country-level Value Analysis
  1. 7.1 Global Veterinary Renal Disease Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Renal Disease Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Renal Disease Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Renal Disease Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Renal Disease Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Renal Disease Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Renal Disease Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary Renal Disease Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Nestle Purina PetCare
  8. 8.2.1 Nestle Purina PetCare Company Information
  9. 8.2.2 Nestle Purina PetCare Business Overview
  10. 8.2.3 Nestle Purina PetCare Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nestle Purina PetCare Veterinary Renal Disease Product Portfolio
  12. 8.2.5 Nestle Purina PetCare Recent Developments
  13. 8.3 Mars
  14. 8.3.1 Mars Company Information
  15. 8.3.2 Mars Business Overview
  16. 8.3.3 Mars Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mars Veterinary Renal Disease Product Portfolio
  18. 8.3.5 Mars Recent Developments
  19. 8.4 Hill's Pet Nutrition
  20. 8.4.1 Hill's Pet Nutrition Company Information
  21. 8.4.2 Hill's Pet Nutrition Business Overview
  22. 8.4.3 Hill's Pet Nutrition Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hill's Pet Nutrition Veterinary Renal Disease Product Portfolio
  24. 8.4.5 Hill's Pet Nutrition Recent Developments
  25. 8.5 The J.M. Smucker Company
  26. 8.5.1 The J.M. Smucker Company Company Information
  27. 8.5.2 The J.M. Smucker Company Business Overview
  28. 8.5.3 The J.M. Smucker Company Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  29. 8.5.4 The J.M. Smucker Company Veterinary Renal Disease Product Portfolio
  30. 8.5.5 The J.M. Smucker Company Recent Developments
  31. 8.6 General Mills
  32. 8.6.1 General Mills Company Information
  33. 8.6.2 General Mills Business Overview
  34. 8.6.3 General Mills Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  35. 8.6.4 General Mills Veterinary Renal Disease Product Portfolio
  36. 8.6.5 General Mills Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Veterinary Renal Disease Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Elanco Animal Health
  44. 8.8.1 Elanco Animal Health Company Information
  45. 8.8.2 Elanco Animal Health Business Overview
  46. 8.8.3 Elanco Animal Health Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Elanco Animal Health Veterinary Renal Disease Product Portfolio
  48. 8.8.5 Elanco Animal Health Recent Developments
  49. 8.9 Phibro Animal Health Corporation
  50. 8.9.1 Phibro Animal Health Corporation Company Information
  51. 8.9.2 Phibro Animal Health Corporation Business Overview
  52. 8.9.3 Phibro Animal Health Corporation Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Phibro Animal Health Corporation Veterinary Renal Disease Product Portfolio
  54. 8.9.5 Phibro Animal Health Corporation Recent Developments
  55. 8.10 Ceva Sante Animale
  56. 8.10.1 Ceva Sante Animale Company Information
  57. 8.10.2 Ceva Sante Animale Business Overview
  58. 8.10.3 Ceva Sante Animale Veterinary Renal Disease Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ceva Sante Animale Veterinary Renal Disease Product Portfolio
  60. 8.10.5 Ceva Sante Animale Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst